Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers
MA Pfeffer - American heart journal, 2000 - Elsevier
Treatment of acute myocardial infarction (MI) has been advanced considerably in the past
20 years with the advent of acute reperfusion strategies such as thrombolytic therapy or …
20 years with the advent of acute reperfusion strategies such as thrombolytic therapy or …
Angiotensin-converting enzyme inhibitors post-myocardial infarction
JB Young - Cardiology Clinics, 1995 - cardiology.theclinics.com
Insight into the pathophysiology of myocardial infarction stimulated strategies to reduce peri-
infarct morbidity and mortality rates. A panoply of procedures and therapeutic adventures …
infarct morbidity and mortality rates. A panoply of procedures and therapeutic adventures …
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design
MA Pfeffer, J McMurray, A Leizorovicz, AP Maggioni… - American heart …, 2000 - Elsevier
Background Survivors of acute myocardial infarction (MI) complicated by heart failure and/or
resulting in left ventricular dysfunction are at heightened risk for subsequent death and …
resulting in left ventricular dysfunction are at heightened risk for subsequent death and …
[PDF][PDF] Angiotensin-receptor blockade in acute myocardial infarction-a matter of dose
DL Mann, A Deswal - New England Journal of Medicine, 2003 - researchgate.net
Beta-blockers, angiotensin-converting–enzyme (ACE) inhibitors, and aldosterone
antagonists have been shown to reduce the overall risk of death as well as the risk of major …
antagonists have been shown to reduce the overall risk of death as well as the risk of major …
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial …
Objectives: We attempted to compare the effect of an angiotensin-converting enzyme (ACE)
inhibitor and angiotensin receptor blocker (ARB) on atherosclerotic events. Background …
inhibitor and angiotensin receptor blocker (ARB) on atherosclerotic events. Background …
Cardioprotection with angiotensin‐converting enzyme inhibitors: Redefined for the 1990s
RA Kloner, K Przyklenk - Clinical cardiology, 1993 - Wiley Online Library
The concept of “cardioprotection” with ACE inhibitors has evolved over the last decade. In
the 1980s, protective benefits of ACE inhibitors in hypertension were established, regression …
the 1980s, protective benefits of ACE inhibitors in hypertension were established, regression …
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
N Bissessor, H White - Vascular health and risk management, 2007 - Taylor & Francis
The physiological role of the renin angiotensin aldosterone system (RAAS) is to maintain the
integrity of the cardiovascular system. The effect of angiotensin II is mediated via the …
integrity of the cardiovascular system. The effect of angiotensin II is mediated via the …
Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials
JB Young - Cardiovascular drugs and therapy, 1995 - Springer
Angiotensin-converting enzyme (ACE) inhibitor therapy has been associated with a
substantial (≥ 20%) reduction in the risk of major ischemic events in two recent clinical trials …
substantial (≥ 20%) reduction in the risk of major ischemic events in two recent clinical trials …
Reducing the risks of sudden death and heart failure post myocardial infarction: utility of optimized pharmacotherapy
J Sackner‐Bernstein - … Indexed and Peer‐Reviewed Journal for …, 2005 - Wiley Online Library
Current guidelines define the standard of care for patients after myocardial infarction (MI),
with particular focus on patients with significant ventricular dysfunction. Inherent in these …
with particular focus on patients with significant ventricular dysfunction. Inherent in these …
Cardiac protection: evolving role of angiotensin receptor blockers
RM Califf, JN Cohn - American Heart Journal, 2000 - Elsevier
Congestive heart failure (HF) is a common and serious public health problem affecting
approximately 5 million Americans. Recent treatment strategies have focused on attenuating …
approximately 5 million Americans. Recent treatment strategies have focused on attenuating …